The live attenuated Actinobacillus pleuropneumoniae triple-deletion mutant ΔapxIC ΔapxIIC ΔapxIV-ORF1 strain, SLW05, immunizes pigs against lethal challenge with Haemophilus parasuis

Clinical and Vaccine Immunology

Volumn 20, Issue 2, 2013, Pages 134-139

  Fu, Shulin ^a   Ou, Jiwen ^a   Zhang, Minmin ^b   Xu, Juan ^a   Liu, Huazhen ^a   Liu, Jinlin ^c   Yuan, Fangyan ^b   Chen, Huanchun ^a   Bei, Weicheng ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c CENTRAL CHINA NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINOBACILLUS PLEUROPNEUMONIAE VACCINE; BACTERIAL VACCINE; GAMMA INTERFERON; INTERLEUKIN 2; LIVE VACCINE; UNCLASSIFIED DRUG;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM MUTANT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELETION MUTANT; DRUG EFFICACY; HAEMOPHILUS INFECTION; HAEMOPHILUS PARASUIS; HUMORAL IMMUNITY; IMMUNIZATION; NONHUMAN; OPEN READING FRAME; PIGLET; PRIORITY JOURNAL; TH1 CELL;

ACTINOBACILLUS INFECTIONS; ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; HAEMOPHILUS INFECTIONS; HAEMOPHILUS PARASUIS; HEMOLYSIN PROTEINS; INTERFERON-GAMMA; INTERLEUKIN-2; SEQUENCE DELETION; SWINE; SWINE DISEASES; VACCINES, ATTENUATED;

EID: 84874916020     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00458-12     Document Type: Article

References (35)

1. Frey J. 2003. Detection, identification, and subtyping of Actinobacillus pleuropneumoniae. Methods Mol. Biol. 216:87-95.
2. Frey J. 1995. Virulence in Actinobacillus pleuropneumoniae and RTX toxins. Trends Microbiol. 3:257-261.
3. Schaller A, Kuhn R, Kuhnert P, Nicolet J, Anderson TJ, MacInnes JI, Segers RP, Frey J. 1999. Characterization of apxIVA, a new RTX deter-minant of Actinobacillus pleuropneumoniae. Microbiology 145:2105-2116.
4. Bandara AB, Lawrence ML, Veit HP, Inzana TJ. 2003. Association of Actinobacillus pleuropneumoniae capsular polysaccharide with virulence in pigs. Infect. Immun. 71:3320-3328.
5. Mekalanos JJ. 1994. Live attenuated vaccine vectors. Int. J. Technol. Assess. Health Care 10:131-142.
6. Inzana TJ, Glindemann G, Fenwick B, Longstreth J, Ward D. 2004. Risk assessment of transmission of capsule-deficient, recombinant Actinobacillus pleuropneumoniae. Vet. Microbiol. 104:63-71.
7. Dröge M, Pühler A, Selbitschka W. 1998. Horizontal gene transfer as a biosafety issue: a natural phenomenon of public concern. J. Biotechnol. 64:75-90.
8. Lin L, Bei W, Sha Y, Liu J, Guo Y, Liu W, Tu S, He Q, Chen H. 2007. Construction and immunogenicity of a ΔapxIC/ΔapxIIC double mutant of Actinobacillus pleuropneumoniae serovar 1. FEMS Microbiol. Lett. 274: 55-62.
9. Yuan F, Liu J, Guo Y, Tan C, Fu S, Zhao J, Chen H, Bei W. 2011. Influences of ORF1 on the virulence and immunogenicity of Actinobacillus pleuropneumoniae. Curr. Microbiol. 63:574-580.
10. Rapp-Gabrielson VJ, Kocur GJ, Clark JT, Muir SK. 1997. Haemophilus parasuis: immunity in swine after vaccination. Vet. Med. 9:83-90.
11. Tadjine M, Mittal KR, Bourdon S, Gottschalk M. 2004. Development of a new serological test for serotyping Haemophilus parasuis isolates and determination of their prevalence in North America. J. Clin. Microbiol. 42:839-840.
12. Turni C, Blackall PJ. 2005. Comparison of the indirect haemagglutination and gel diffusion test for serotyping Haemophilus parasuis. Vet. Microbiol. 106:145-151.
13. Rappuoli R, Miller HI, Falkows S. 2002. Medicine: the intangible value of vaccination. Science 297:937-939.
14. Takahashi K, Naga S, Yagihashi T, Ikehata T, Nakano Y, Senna K, Maruyama T, Murofushi J. 2001. A cross-protection experiment in pigs vaccinated with Haemophilus parasuis serovars 2 and 5 bacterins, and evaluation of a bivalent vaccine under laboratory and field conditions. J. Vet. Med. Sci. 63:487-491.
15. Cai X, Chen H, Blackall PJ, Yin Z, Wang L, Liu Z, Jin M. 2005. Serological characterization of Haemophilus parasuis isolates from China. Vet. Microbiol. 111:231-236.
16. Jolie RA, Mulks MH, Thacker BJ. 1995. Cross-protection experiments in pigs vaccinated with Actinobacillus pleuropneumoniae subtypes 1A and 1B. Vet. Microbiol. 45:383-391.
17. Blanco I, Canals A, Evans G, Mellencamp MA, Cia C, Deeb N, Wang L, Galina-Pantoja L. 2008. Differences in susceptibility to Haemophilus parasuis infection in pigs. Can. J. Vet. Res. 72:228-235.
18. Hannan PC, Bhogal BS, Fish JP. 1982. Tylosin tartrate and tiamutilin effects on experimental piglet pneumonia induced with pneumonic pig lung homogenate containing mycoplasmas, bacteria and viruses. Res. Vet. Sci. 33:76-88.
19. Shin MK, Kang ML, Cha SB, Lee WJ, Sung JH, Yoo HS. 2011. An immunosorbent assay based on the recombinant ApxIa, ApxIIa, and ApxIIIa toxins of Actinobacillus pleuropneumoniae and its application to field sera. J. Vet. Diagn. Invest. 23:736-742.
20. Wasiń ski B, Pejsak Z. 2012. Reactivity of heat-stable Leptospira antigenic preparation used in enzyme-linked immunosorbent assay for detection of antibodies in swine serum. Pol. J. Vet. Sci. 15:31-36.
21. Furano K, Campagnari AA. 2003. Inactivation of the Moraxella catarrhalis 7169 ferric uptake regulator increases susceptibility to the bactericidal activity of normal human sera. Infect. Immun. 71:1843-1848.
22. Gottschalk M, Taylor DJ. 2006. Actinobacillus pleuropneumoniae, p 563-576. In Straw BE, Zimmerman JJ, D'Allaire S, Taylor DJ (ed), Diseases of swine. Blackwell Publishing Professional, Ames, IA.
23. Oliveira S, Pijoan C. 2004. Haemophilus parasuis: new trends on diagnosis, epidemiology and control. Vet. Microbiol. 99:1-12.
24. Bei W, He Q, Yan L, Fang L, Tan Y, Xiao S, Zhou R, Jin M, Guo A, Lv J, Huang H, Chen H. 2005. Construction and characterisation of a live, attenuated apxIICA inactivation mutant of Actinobacillus pleuropneumoniae lacking a drug resistance marker. FEMS Microbiol. Lett. 243:21-27.
25. Liu J, Chen X, Lin L, Tan C, Chen Y, Guo Y, Jin M, Guo A, Bei W, Chen H. 2007. Potential use an Actinobacillus pleuropneumoniae double mutant strain ΔapxIICΔapxIVA as live vaccine that allows serological differentiation between vaccinated and infected animals. Vaccine 25:7696-7705.
26. Bak H, Riising HJ. 2002. Protection of vaccinated pigs against experimental infections with homologous and heterologous Haemophilus parasuis. Vet. Rec. 151:502-505.
27. Hoffmann CR, Bilkei G. 2002. The effect of a homologous bacterin given to sows prefarrowing on the development of Glässer's disease in postweaning pigs after i.v. challenge with Haemophilus parasuis serotype 5. Dtsch. Tierarztl. Wochenschr. 109:271-276.
28. Palzer A, Ritzmann M, Heinritzi K. 2007. A field trial for early vaccination against Gässer's disease using Porcilis Glässer. Schweiz. Arch. Tierheilkd. 149:389-394.
29. Martín de la Fuente AJ, Rodríguez-Ferri EF, Frandoloso R, Martínez S, Tejerina F, Gutiérrez-Martín CB. 2009. Systemic antibody response in colostrum-deprived pigs experimentally infected with Haemophilus parasuis. Res. Vet. Sci. 86:248-253.
30. Furesz SE, Mallard BA, Bossé JT, Rosendal S, Wilkie BN, MacInnes JI. 1997. Antibody- and cell-mediated immune responses of Actinobacillus pleuropneumoniae-infected and bacterin-vaccinated pigs. Infect. Immun. 65:358-365.
31. - mutant lacking a drug resistance marker in the pigs. Vet. Microbiol. 125:120-127.
32. Fuller TE, Thacker BJ, Duran CO, Mulks MH. 2000. A geneticallydefined riboflavin auxotroph of Actinobacillus pleuropneumoniae as a live attenuated vaccine. Vaccine 18:2867-2877.
33. Chang YF, Chen CS, Palaniappan RU, He H, McDonough SP, Barr SC, Yan W, Faisal SM, Pan MJ, Chang CF. 2007. Immunogenicity of the recombinant leptospiral putative outer membrane proteins as vaccine candidates. Vaccine 25:8190-8197.
34. Chiang CH, Huang WF, Huang LP, Lin SF, Yang WJ. 2009. Immunogenicity and protective efficacy of ApxIA and ApxIIADNAvaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model. Vaccine 27:4565-4570.
35. Zhou M, Guo Y, Zhao J, Hu Q, Hu Y, Zhang A, Chen H, Jin M. 2009. Identification and characterization of nove immunogenic outer membrane proteins of Haemophilus parasuis serovar 5. Vaccine 27:5271-5277.